1
Rutten, Karlijn H G, Raymakers, Reinier A P, Hazenberg, Bouke P C, Nienhuis, Hans L A, Vellenga, Edo, Minnema, Monique C
Veröffentlicht in: Rutten , K H G , Raymakers , R A P , Hazenberg , B P C , Nienhuis , H L A , Vellenga , E & Minnema , M C 2018 , ' Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016 ' , Amyloid , vol. 25 , no. 4 , pp. 227-233 . https://doi.org/10.1080/13506129.2018.1536043;
2018
Veröffentlicht in: Rutten , K H G , Raymakers , R A P , Hazenberg , B P C , Nienhuis , H L A , Vellenga , E & Minnema , M C 2018 , ' Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016 ' , Amyloid , vol. 25 , no. 4 , pp. 227-233 . https://doi.org/10.1080/13506129.2018.1536043;
2018
2
Slot, Stefanie, Raymakers, Reinier A. P., Schaap, Nicolaas, Span, Lambert F. R., Koene, Harry R., Kersting, Sabina, Boekhorst, Peter A. W. te, Westerman, Matthijs, Schouten, Harry C., Zweegman, Sonja
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
3
Hazenberg, Bouke P. C., Croockewit, Alexandra, van der Holt, Bronno, Zweegman, Sonja, Bos, Gerard M. J., Delforge, Michel, Raymakers, Reinier A. P., Sonneveld, Pieter, Vellenga, Edo, Wijermans, Pierre W., von dem Borne, Peter A., van Oers, Marinus H., de Weerdt, Okke, Spoelstra, Fokje M., Lokhorst, Henk M.
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M , Lokhorst , H M & Dutch-Belgian Cooperative Trial Gr 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324//haematol.2014.119198;
2015
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M , Lokhorst , H M & Dutch-Belgian Cooperative Trial Gr 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324//haematol.2014.119198;
2015